Joseph C. Geagea - Feb 25, 2022 Form 4 Insider Report for CHEVRON CORP (CVX)

Role: Executive Vice President
Signature: /s/ Rose Z. Pierson, Attorney-in-Fact for Joseph C. Geagea
Stock symbol: CVX
Transactions as of: Feb 25, 2022
Transactions value $: -$1,561,070
Form type: 4
Date filed: 3/1/2022, 05:01 PM
Previous filing: Feb 15, 2022
Next filing: May 6, 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CVX	Common Stock	Options Exercise	$4.66M	+40K	+3218.02%	$116.45	41.2K	Feb 25, 2022	Direct
transaction	CVX	Common Stock	Sale	-$2.76M	-20K	-48.49%	$138.00	21.2K	Feb 25, 2022	Direct
transaction	CVX	Common Stock	Sale	-$2.8M	-20K	-94.15%	$140.00	1.24K	Feb 25, 2022	Direct
transaction	CVX	Common Stock	Options Exercise	$1.16M	+10K	+804.51%	$116.00	11.2K	Feb 28, 2022	Direct
transaction	CVX	Common Stock	Options Exercise	$1.04M	+10K	+88.94%	$103.71	21.2K	Feb 28, 2022	Direct
transaction	CVX	Common Stock	Sale	-$2.86M	-20K	-94.15%	$142.81	1.24K	Feb 28, 2022	Direct	F1
holding	CVX	Common Stock						25.5K	Feb 25, 2022	by 401(k) plan
holding	CVX	Common Stock						2.5K	Feb 25, 2022	By Geagea Family Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CVX	Non-Qualified Stock Option (Right to Buy)	Options Exercise	$0	-40K	-100%	$0.00^*	0	Feb 25, 2022	Common Stock	40K	$116.45	Direct	F2
transaction	CVX	Non-Qualified Stock Option (Right to Buy)	Options Exercise	$0	-10K	-11.11%	$0.00	80K	Feb 28, 2022	Common Stock	10K	$116.00	Direct	F3
transaction	CVX	Non-Qualified Stock Option (Right to Buy)	Options Exercise	$0	-10K	-6.67%	$0.00	140K	Feb 28, 2022	Common Stock	10K	$103.71	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This transaction was executed in multiple trades at prices ranging from $142.80 to $142.87. The price reported above reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F2	Option granted 1/30/2013. One-third of the shares subject to the option vested on each of the first, second and third anniversaries of the date of grant.
F3	Option granted 1/29/2014. One-third of the shares subject to the option vested on each of the first, second and third anniversaries of the date of grant.
F4	Option granted 1/28/2015. One-third of the shares subject to the option vested on each of the first, second and third anniversaries of the date of grant.